Logo Medical Data Models (MDM) Portal Logo Westfälische Wilhelms-Universität (WWU)
Information:
Error:
en ▾
  • Deutsch
  • English
  • Español
  • Italiano
  • Français
  • Português
  • Svenska
  • Nederlands
  • Login
  • Register
  • Search
  • ODM-XML file upload
  • Create data model
  • ODM-Edit tool
  • Metadata Registry
  • Help
  • About the MDM portal
  • Imprint
  • Login
  • Register
Actions ▾
  • ODM-XML file upload
  • Create data model
  • ODM-Edit tool
  • Metadata Registry
  • About the MDM portal
en ▾
  • Deutsch
  • English
  • Español
  • Italiano
  • Français
  • Português
  • Svenska
  • Nederlands

Search through specific fields of a model

The name of the data model contains study:
name:"study"
The description contains two terms:
description:"double blind"
The copyrightholder contains the term UKM:
copyrightholder:"UKM"
The uploader of the model is Martin Dugas:
uploader:"Martin Dugas"
The keywords contain cancer:
keyword:"cancer"

Refine the search with search operators

Search for groups of words with quotes:
"leukemia myeloid"
Use a wildcard to search for prefixes:
NCT*
With AND/OR/NOT find study without eye nor ear:
study AND NOT (eye OR ear)
Cancer must (+) occur, study not (-):
+cancer -study
You may connect the different search techniques:
name:"form*" AND routine
  • Filter search results
Keywords
Macular Edema ×
  • Clinical Trial  (321)
  • Ophthalmology  (318)
  • Diabetes Mellitus  (303)
  • Clinical Trial, Phase III  (263)
  • Laser Therapy  (73)
  • Drug Therapy  (64)
  • Vision Tests  (48)
  • Medical History Taking  (23)
  • Retinal Vein Occlusion  (18)
  • Physical Examination  (13)
  • Visual Acuity  (11)
  • Slit Lamp  (9)
  • Ophthalmoscopy  (9)
  • Vital Signs  (8)
  • Eligibility Determination  (8)
  • Intraocular Pressure  (7)
  • Adverse event  (6)
  • Therapeutics  (5)
  • Demography  (5)
  • Organization and Administration  (5)
  • Questionnaires  (4)
  • Patient Outcome Assessment  (4)
  • Concomitant Medication  (4)
  • Informed Consent  (4)
  • Language  (4)
  • Alcohol Drinking  (3)
  • Smoking  (2)
  • Contrast Sensitivity  (2)
  • Substance Abuse Detection  (2)
  • Cross-Over Studies  (2)
  • Tobacco Use  (2)
  • Aftercare  (2)
  • Drug Administration Schedule  (2)
  • Drug Evaluation  (2)
  • Eye  (2)
  • Reading  (1)
  • Substance-Related Disorders  (1)
  • Quality Assurance  (1)
  • Diabetic Retinopathy  (1)
  • Alcoholism  (1)
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
  • Select data models
Selected data models

You must log in to select data models for download or further analysis.

322 Search results.

Sort (Relevance) ▾
  • Relevance
  • Rating
  • New first
  • Old first

LASER ADMINISTRATION FELLOW EYE (UNSCHEDULED) CRFs Roche FVF4170G Macular Edema NCT00473382

- 6/28/17 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Patient administration, LASER ADMINISTRATION STUDY EYE
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4168g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus
  • Macular Edema
  • Ophthalmology
  • Laser Therapy
  • Clinical Trial
  • Diabetes Mellitus
  • Clinical Trial, Phase III

CONCURRENT OCULAR PROCEDURES (DAY 0 - MONTH 12) CRFs Roche FVF4170G Macular Edema NCT00473382

- 6/11/17 - 1 form, 3 itemgroups, 12 items, 1 language
Itemgroups: Patient administration, CONCURRENT OCULAR PROCEDURES (DAY 0 - MONTH 12), Procedure
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus
  • Therapeutics
  • Ophthalmology
  • Clinical Trial
  • Diabetes Mellitus
  • Macular Edema
  • Clinical Trial, Phase III

SUBJECT ELIGIBILITY (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382

- 6/8/17 - 1 form, 3 itemgroups, 9 items, 1 language
Itemgroups: Patient administration, SUBJECT ELIGIBILITY, Eligibility Criteria Not Met
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus
  • Clinical Trial
  • Clinical Trial, Phase III
  • Eligibility Determination
  • Macular Edema
  • Diabetes Mellitus
  • Ophthalmology

Vital Signs Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4168g - Vital Signs Screening

- 3/21/18 - 1 form, 1 itemgroup, 13 items, 1 language
Itemgroup: Vital Signs
Study part: Vital Signs Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.
  • Diabetes Mellitus
  • Ophthalmology
  • Vital Signs
  • Macular Edema
  • Physical Examination
  • Clinical Trial

Physical Exam Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4168g - Physical Exam Screening

- 3/21/18 - 1 form, 1 itemgroup, 5 items, 1 language
Itemgroup: Physical examination
Study part: Physical Exam Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.
  • Ophthalmology
  • Macular Edema
  • Diabetes Mellitus
  • Clinical Trial
  • Physical Examination

Intraocular Pressure Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4168g - Intraocular Pressure Screening

- 3/21/18 - 1 form, 1 itemgroup, 9 items, 1 language
Itemgroup: Intraocular Pressure
Study part: Intraocular Pressure Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.
  • Diabetes Mellitus
  • Intraocular Pressure
  • Clinical Trial
  • Ophthalmology
  • Macular Edema

Slitlamp Examination Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4168g - Slitlamp Examination Screening

- 3/21/18 - 1 form, 4 itemgroups, 48 items, 1 language
Itemgroups: Slitlamp Examination Right Eye, Slitlamp Examination Left Eye , Findings of Inflammation right eye, Findings of Inflammation left eye
Study part: Slitlamp Examination Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.
  • Macular Edema
  • Diabetes Mellitus
  • Ophthalmology
  • Slit Lamp
  • Clinical Trial

General Medical History and Baseline Conditions Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4168g - General Medical History and Baseline Conditions Screening

- 3/21/18 - 1 form, 1 itemgroup, 8 items, 1 language
Itemgroup: Medical History
Study part: General Medical History and Baseline Conditions Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.
  • Medical History Taking
  • Ophthalmology
  • Clinical Trial
  • Diabetes Mellitus
  • Macular Edema

Targeted Medical History and Baseline Conditions Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4168g - Targeted Medical History and Baseline Conditions Screening

- 3/21/18 - 1 form, 1 itemgroup, 11 items, 1 language
Itemgroup: Medical History
Study part: Targeted Medical History and Baseline Conditions Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.
  • Macular Edema
  • Ophthalmology
  • Clinical Trial
  • Diabetes Mellitus
  • Medical History Taking

Non Ocular Surgery/ Procedure History Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4168g - Non Ocular Surgery/ Procedure History Screening

- 3/21/18 - 1 form, 1 itemgroup, 7 items, 1 language
Itemgroup: Medical History surgery
Study part: Non Ocular Surgery/ Procedure History Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.
  • Clinical Trial
  • Diabetes Mellitus
  • Macular Edema
  • Ophthalmology
  • Medical History Taking

4 Meter Visual Acuity/ Left Eye Chart 2 Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4168g - 4 Meter Visual Acuity/ Left Eye Chart 2 Screening

- 3/21/18 - 1 form, 4 itemgroups, 28 items, 1 language
Itemgroups: Visual acuity, Visual acuity, total score, Vision Tests
Study part: 4 Meter Visual Acuity/ Left Eye Chart 2 Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.
  • Diabetes Mellitus
  • Macular Edema
  • Clinical Trial
  • Visual Acuity
  • Ophthalmology

4 Meter Visual Acuity/ Right Eye Chart 1 Ranibizumab Macular Edema Diabetes Mellitus FVF4168g - 4 Meter Visual Acuity/ Right Eye Chart 1

- 3/21/18 - 1 form, 4 itemgroups, 28 items, 1 language
Itemgroups: Visual acuity, Visual acuity, total score, Vision Tests
Study part: 4 Meter Visual Acuity/ Right Eye Chart 1. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.
  • Ophthalmology
  • Macular Edema
  • Visual Acuity
  • Clinical Trial
  • Diabetes Mellitus
  • 1
  • 2 (current)
  • 3
  • 4
  • 5
  • …
  • 27
  • >

Contact

Institute of Medical Informatics
Director: Prof. Dr. Martin Dugas
Albert-Schweitzer-Campus 1, A11
48149 Münster, Germany
Email : imi@uni-muenster.de

In collaboration with

Logo DFG Logo ERCIS Logo IMI Logo CatRIS Logo ULB Logo IH-D Logo Toolpool Logo EFMI
  • Imprint
  • Disclaimer
  • Data Privacy
© 2021  University of Münster
  • Contact
  • Help
  • Cite

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Login

Forgot password?


Register